QA: Immix Biopharma Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001873835_2025_Immix_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001873835, Immix Biopharma Inc

  xvar xval
0 AssetsCurrent 20,197,834
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,740,149
3 remainder_Assets 1,009,889
4 LiabilitiesCurrent 8,687,118
5 LiabilitiesNoncurrent 1,009,551
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,261,458
9 ResearchAndDevelopmentExpense 18,693,241
10 remainder_Expenses 114,146
11 remainder_Revenues 0
12 remainder_NetIncome 867,461
13 remainder_ComprehensiveNetIncome 216,397
  yvar yval
0 Assets 22,947,872
1 Liabilities 9,696,669
2 Expenses 50,068,845
3 Revenues 0
4 StockholdersEquity 13,251,203
5 NetIncome -49,201,384
6 ComprehensiveNetIncome -49,093,186
7 BaseVar 41,898,622
8 EconomicCapitalRatiobeforeLimitedLiability -1.24
9 EconomicCapitalRatio 1.25

Edgar->Model Mapping

Feature Distribution

Change over Time